Tag: influenza diagnostic market top players

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Influenza Diagnostic Global Market Report 2024 Market from 2024 to 2033?

The influenza diagnostic market has shown strong growth in recent years. It will increase from $2.59 billion in 2023 to $2.79 billion in 2024, with a CAGR of 7.6%. The growth is attributed to public health concerns, technological advancements, antiviral medications, and pandemic preparedness.

The influenza diagnostic market is expected to experience strong growth, reaching $3.68 billion by 2028 at a CAGR of 7.2%. Factors driving this growth include seasonal influenza, point-of-care testing, and remote testing. Trends include molecular diagnostics, antigen-based tests, and automation.

Claim Your Free Sample of the Global Influenza Diagnostic Global Market Report 2024 Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

What Key Factors Are Fueling the Growth of the Influenza Diagnostic Global Market Report 2024 Market?

The growth of the influenza diagnostic market is anticipated to be driven by the increasing use of rapid diagnostic tests. These tests help confirm or rule out medical conditions by detecting viral antigens in a short timeframe of 10-15 minutes, with moderate sensitivity (50-70%). For example, the CDC reported that from September 2020 to May 2021, 0.2% of respiratory samples tested in the U.S. were positive for the influenza virus. Therefore, the widespread adoption of rapid diagnostic tests is expected to significantly impact the influenza diagnostic market.

What Are the Major Segments of the Influenza Diagnostic Global Market Report 2024 Market?

1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

What New Trends Are Transforming the Influenza Diagnostic Global Market Report 2024 Market?

Leading companies in the influenza diagnostic market are developing innovative products such as the Lucira COVID-19 & Flu Home Test for rapid simultaneous detection of flu and COVID-19. In February 2023, Pfizer Inc. received approval for the Lucira by Pfizer COVID-19 & Flu Home Test, which provides results from self-collected nasal swabs within 30 minutes, detecting both influenza A and B and SARS-CoV-2.

Order Now for Fast Delivery of Your Influenza Diagnostic Global Market Report 2024 Market Report!

https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Which Regions Are Driving Growth in the Influenza Diagnostic Global Market Report 2024 Market?

North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Influenza Diagnostic Global Market Report 2024 Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the influenza diagnostic global market report 2024 market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Influenza Diagnostic Global Market Report 2024 Market Include

1. Influenza Diagnostic Global Market Report 2024 Market Executive Summary

2. Influenza Diagnostic Global Market Report 2024 Market Segments

3. Influenza Diagnostic Global Market Report 2024 Market Size And Template Market Growth Rate

4. Key Influenza Diagnostic Global Market Report 2024 Market Trends

5. Major Influenza Diagnostic Global Market Report 2024 Market Drivers

……

25. Key Mergers And Acquisitions In The Influenza Diagnostic Global Market Report 2024 Market

26. Top Influenza Diagnostic Global Market Report 2024 Companies

27. Influenza Diagnostic Global Market Report 2024 Market Opportunities And Strategies

28. Influenza Diagnostic Global Market Report 2024 Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Immunofluorescence Assay Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

Molecular Biology Enzymes & Kits & Reagents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-biology-enzymes-and-kits-and-reagents-global-market-report

Global Molecular Diagnostics Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The influenza diagnostic market is poised for substantial growth in the coming years, with an expected surge to $3.68 billion in 2028, boasting a Compound Annual Growth Rate (CAGR) of 7.2%. This growth is attributed to factors such as the prevalence of seasonal influenza, the rise of point-of-care testing, the adoption of remote and home testing, and the integration of digital health solutions.

Rapid Diagnostic Tests: Propelling Market Growth

Understanding Diagnostic Tests
Diagnostic tests play a crucial role in confirming or ruling out various conditions and diseases. Rapid influenza diagnostic tests (RIDTs) are set to be a significant driver in the influenza diagnostic market. These tests can swiftly detect influenza viral antigens within 10-15 minutes, offering moderate sensitivity (50-70%). According to the Centers for Disease Control and Prevention (CDC), during September 2020 to May 2021 in the United States, 0.2% of respiratory specimens tested were positive for an influenza virus, highlighting the importance of rapid diagnostic tests.

Key Market Players
Major players in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, and Hologic Inc., among others. These companies are at the forefront of developing and providing innovative diagnostic solutions to meet the growing demand for influenza testing.

Simultaneous Detection: A Breakthrough in Diagnosis
Innovative Products Leading the Way
Major companies in the influenza diagnostic market are focusing on innovation, introducing breakthrough products like the Lucira COVID-19 & Flu Home Test. This at-home test kit allows simultaneous qualitative detection of influenza A and B (commonly known as the flu) and SARS-CoV-2 (the virus causing COVID-19). Pfizer Inc. received approval for this test in February 2023, highlighting the industry’s commitment to providing convenient and comprehensive diagnostic solutions.

Read More On The Influenza Diagnostic Market Report 2024 – https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

Strength in Integration
The Lucira COVID-19 & Flu Home Test exemplifies the integration of diagnostic capabilities. With results available in approximately 30 minutes from self-collected nasal swab samples, this test showcases the industry’s dedication to offering rapid and reliable diagnostic solutions for both influenza and COVID-19.

Thermo Fisher’s Strategic Move: Mesa Biotech Acquisition
Strengthening Diagnostic Capabilities
In February 2021, Thermo Fisher Scientific Inc. made a strategic move by acquiring Mesa Biotech, Inc., an infectious disease diagnostic company. This acquisition aims to enhance Thermo Fisher’s manufacturing volume, achieve cost efficiencies, and expedite the delivery of diagnostics to the market on a larger scale. Such strategic partnerships and acquisitions contribute to the overall advancement and growth of the influenza diagnostic market.

Market Segmentation: Navigating the Landscape
Understanding Diagnostic Tests
The influenza diagnostic market is intricately segmented based on traditional diagnostic tests and molecular diagnostic tests. Traditional diagnostic tests include Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological assays, and other traditional diagnostic tests. On the other hand, molecular diagnostic tests encompass Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop-Mediated Isothermal Based Amplification Assays, and other molecular diagnostic tests.

End User Perspectives
End-user segments in the influenza diagnostic market include Hospitals and Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, and Other End Users. Understanding these segments is crucial for comprehending the diverse applications and demands within the influenza diagnostic landscape.

Regional Leadership: North America Takes the Lead
Dominance in 2023
In 2023, North America emerged as the largest region in the influenza diagnostic market. This regional dominance can be attributed to a robust healthcare infrastructure, technological advancements, and a proactive approach in adopting diagnostic solutions. As the market continues to evolve, North America remains a key player shaping the trajectory of influenza diagnostics.

In conclusion, the influenza diagnostic market is on the cusp of significant growth, driven by the rise of rapid diagnostic tests, simultaneous detection solutions, strategic acquisitions, and a comprehensive understanding of market segmentation. With advancements in diagnostic technologies, the industry is poised to play a pivotal role in efficiently managing influenza and other respiratory illnesses in the years to come.

Request for A Sample Of The Global Influenza Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=3237&type=smp